NHU(SZ:002001)2025-04-28 10:05Financial Performance - The company's revenue for Q1 2025 reached ¥5,439,577,817.97, representing a year-on-year increase of 20.91% compared to ¥4,498,764,263.04 in the same period last year[5] - Net profit attributable to shareholders was ¥1,879,910,462.58, a significant increase of 116.18% from ¥869,622,923.96 in the previous year[5] - Basic earnings per share rose to ¥0.61, up 117.86% from ¥0.28 in the previous year[5] - Operating profit for the current period was ¥2,143,877,229.15, up 99.9% from ¥1,072,533,968.01 in the previous period[24] - Net profit attributable to the parent company was ¥1,879,910,462.58, a significant increase of 116.3% compared to ¥869,622,923.96 in the previous period[24] Cash Flow - The net cash flow from operating activities increased by 231.88%, amounting to ¥1,595,982,605.81, compared to ¥480,895,414.07 in the same period last year[5] - Cash inflow from operating activities totaled ¥5,715,288,486.58, an increase from ¥4,009,459,847.44 in the previous period[26] - The net cash flow from operating activities was CNY 1,595,982,605.81, a significant increase from CNY 480,895,414.07 in the previous period, representing a growth of approximately 232%[27] - Cash inflow from financing activities was CNY 572,494,106.93, down from CNY 1,130,900,749.27, a decrease of approximately 49%[27] - The net cash flow from financing activities was CNY -545,176,666.55, compared to a positive CNY 56,722,688.55 in the previous period[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥43,777,419,398.69, reflecting a 1.83% increase from ¥42,989,132,470.97 at the end of the previous year[5] - The company's current assets totaled CNY 18,034,022,364.43, up from CNY 16,922,201,085.10 at the start of the period, reflecting a growth of approximately 6.58%[20] - The total liabilities decreased to CNY 13,020,168,261.57 from CNY 13,543,582,208.04, showing a reduction of about 3.87%[21] - The company's total equity remained stable at CNY 30,757,421,680.00, unchanged from the previous period[21] Investment and Expenses - The company reported a 583.44% increase in investment income, primarily due to higher returns from joint ventures[14] - The company experienced a 246.21% decrease in financial expenses, attributed to increased foreign exchange gains[9] - Research and development expenses increased to ¥256,931,534.29, up from ¥202,953,832.19 in the previous period, reflecting a focus on innovation[23] - The company reported a significant reduction in financial expenses, with a net financial cost of -¥62,451,557.05 compared to ¥42,714,986.04 in the previous period[23] Changes in Cash and Equivalents - The company's cash and cash equivalents net increase decreased by 411.30%, mainly due to increased expenditures on bank wealth management products and special dividend payments[11] - The company's cash and cash equivalents decreased to CNY 7,464,811,535.54 from CNY 7,936,504,805.65, indicating a decline of about 5.93%[19] - The total cash and cash equivalents at the end of the period amounted to CNY 5,136,830,236.59, a decrease from CNY 4,570,125,619.38 year-over-year[27] Other Financial Metrics - The weighted average return on equity increased by 2.85 percentage points to 6.29% from 3.44% in the previous year[5] - Other comprehensive income after tax attributable to the parent company was ¥14,918,970.14, compared to a loss of ¥2,054,048.56 in the previous period[24] - The cash outflow for debt repayment was CNY 443,917,925.63, down from CNY 1,003,043,623.32, a decrease of about 56%[27] Corporate Actions - The company completed the absorption merger of its wholly-owned subsidiaries, increasing the registered capital of the surviving entity from CNY 400 million to CNY 900 million[17] - The company has not disclosed any related party transactions or significant asset restructuring in the recent period[17]